From basic research to clinical development of MEK1/2 inhibitors for cancer therapy

por Frémin, Christophe, Meloche, Sylvain
Publicado 2010

The MAPK MEK1/2-ERK1/2 Pathway and Its Implication in Hepatocyte Cell Cycle Control

por Guégan, Jean-Philippe, Frémin, Christophe, Baffet, Georges
Publicado 2012

Redundancy in the World of MAP Kinases: All for One

por Saba-El-Leil, Marc K., Frémin, Christophe, Meloche, Sylvain
Publicado 2016

Phosphoproteome dynamics reveal novel ERK1/2 MAP kinase substrates with broad spectrum of functions

por Courcelles, Mathieu, Frémin, Christophe, Voisin, Laure, Lemieux, Sébastien, Meloche, Sylvain, Thibault, Pierre
Publicado 2013